Jefferies Keeps Their Buy Rating on Argenx Se (ARGX)
I'm PortAI, I can summarize articles.
Jefferies analyst Akash Tewari maintained a Buy rating on Argenx Se with a $950 price target. Tewari, a 5-star analyst, has a 13.6% average return and a 55.18% success rate. Argenx Se also received a Buy rating from Wells Fargo's Derek Archila, while UBS maintained a Hold rating. Tewari covers the Healthcare sector, including Pfizer and BioNTech SE.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments